The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Identification of Lynch Syndrome Among Patients With Colorectal Cancer
Open accessAbstract
CONTEXT: Lynch syndrome is the most common form of hereditary colorectal cancer (CRC) and is caused by germline mutations in DNA mismatch repair (MMR) genes. Identification of gene carriers currently relies on germline analysis in patients with MMR-deficient tumors, but criteria to select individuals in whom tumor MMR testing should be performed are unclear. OBJECTIVE: To establish a highly sensitive and efficient strategy for the identification of MMR gene mutation carriers among CRC probands. DESIGN, SETTING, AND PATIENTS: Pooled-data analysis of 4 large cohorts of newly diagnosed CRC probands recruited between 1994 and 2010 (n = 10,206) from the Colon Cancer Family Registry, the EPICOLON project, the Ohio State University, and the University of Helsinki examining personal, tumor-related, and family characteristics, as well as microsatellite instability, tumor MMR immunostaining, and germline MMR mutational status data. MAIN OUTCOME: Performance characteristics of selected strategies (Bethesda guidelines, Jerusalem recommendations, and those derived from a bivariate/multivariate analysis of variables associated with Lynch syndrome) were compared with tumor MMR testing of all CRC patients (universal screening). RESULTS: Of 10,206 informative, unrelated CRC probands, 312 (3.1%) were MMR gene mutation carriers. In the population-based cohorts (n = 3671 probands), the universal screening approach (sensitivity, 100%; 95% CI, 99.3%-100%; specificity, 93.0%; 95% CI, 92.0%-93.7%; diagnostic yield, 2.2%; 95% CI, 1.7%-2.7%) was superior to the use of Bethesda guidelines (sensitivity, 87.8%; 95% CI, 78.9%-93.2%; specificity, 97.5%; 95% CI, 96.9%-98.0%; diagnostic yield, 2.0%; 95% CI, 1.5%-2.4%; P < .001), Jerusalem recommendations (sensitivity, 85.4%; 95% CI, 77.1%-93.6%; specificity, 96.7%; 95% CI, 96.0%-97.2%; diagnostic yield, 1.9%; 95% CI, 1.4%-2.3%; P < .001), and a selective strategy based on tumor MMR testing of cases with CRC diagnosed at age 70 years or younger and in older patients fulfilling the Bethesda guidelines (sensitivity, 95.1%; 95% CI, 89.8%-99.0%; specificity, 95.5%; 95% CI, 94.7%-96.1%; diagnostic yield, 2.1%; 95% CI, 1.6%-2.6%; P < .001). This selective strategy missed 4.9% of Lynch syndrome cases but resulted in 34.8% fewer cases requiring tumor MMR testing and 28.6% fewer cases undergoing germline mutational analysis than the universal approach. CONCLUSION: Universal tumor MMR testing among CRC probands had a greater sensitivity for the identification of Lynch syndrome compared with multiple alternative strategies, although the increase in the diagnostic yield was modest.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., & Thun, M. J. (2009) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20006 · Cited by 9,709
Boland, C. R., Thibodeau, S. N., Hamilton, S. R., Sidransky, D., Eshleman, J. R., Burt, R. W., Meltzer, S. J., Rodrı́guez-Bigas, M. A., Fodde, R., Ranzani, G. N., et al. (1998) · PubMed · Cited by 4,087
Self-citationUmar, A., Boland, C. R., Terdiman, J. P., Syngal, S., Chapelle, A. D. L., Ruschoff, J., Fishel, R., Lindor, N. M., Burgart, L. J., Hamelin, R., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh034 · Cited by 3,183
Self-citationVASEN, H., WATSON, P., MECKLIN, J., & LYNCH, H. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70510-x · Cited by 2,519
Lynch, H. T., & de la Chapelle, A. (2003) · New England Journal of Medicine · doi:10.1056/nejmra012242 · Cited by 2,203
Self-citationThe International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC)
Vasen, H. F. A., Mecklin, J. P., Meera Khan, P., & Lynch, H. T. (1991) · Diseases of the Colon & Rectum · doi:10.1007/bf02053699 · Cited by 2,147
Assessing the accuracy of prediction algorithms for classification: an overview
Baldi, P., Brunak, S., Chauvin, Y., Andersen, C. A. F., & Nielsen, H. (2000) · Bioinformatics · doi:10.1093/bioinformatics/16.5.412 · Cited by 2,111
Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer)
Hampel, H., Frankel, W. L., Martin, E., Arnold, M., Khanduja, K., Kuebler, P., Nakagawa, H., Sotamaa, K., Prior, T. W., Westman, J., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043146 · Cited by 1,408
Self-citationAaltonen, L. A., Salovaara, R., Kristo, P., Canzian, F., Hemminki, A., Peltomäki, P., Chadwick, R. B., Kääriäinen, H., Eskelinen, M., Järvinen, H., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199805213382101 · Cited by 1,152
Self-citationFeasibility of Screening for Lynch Syndrome Among Patients With Colorectal Cancer
Hampel, H., Frankel, W. L., Martin, E., Arnold, M., Khanduja, K., Kuebler, P., Clendenning, M., Sotamaa, K., Prior, T., Westman, J. A., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.5950 · Cited by 876
Self-citationLindor, N. M., Petersen, G. M., Hadley, D. W., Kinney, A. Y., Miesfeldt, S., Lu, K. H., Lynch, P., Burke, W., & Press, N. (2006) · JAMA · doi:10.1001/jama.296.12.1507 · Cited by 629
Self-citationLife‐time risk of different cancers in hereditary non‐polyposis colorectal cancer (hnpcc) syndrome
Aarnio, M., Mecklin, J., Aaltonen, L. A., Nyström‐Lahti, M., & Järvinen, H. J. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910640613 · Cited by 599
Self-citationPopulation-Based Molecular Detection of Hereditary Nonpolyposis Colorectal Cancer
Salovaara, R., Loukola, A., Kristo, P., Kääriäinen, H., Ahtola, H., Eskelinen, M., Härkönen, N., Julkunen, R., Kangas, E., Ojala, S., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.11.2193 · Cited by 516
Self-citationIdentification and Survival of Carriers of Mutations in DNA Mismatch-Repair Genes in Colon Cancer
Barnetson, R. A., Tenesa, A., Farrington, S. M., Nicholl, I. D., Cetnarskyj, R., Porteous, M. E., Campbell, H., & Dunlop, M. G. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053493 · Cited by 477
Wijnen, J. T., Vasen, H. F. A., Khan, P. M., Zwinderman, A. H., van der Klift, H., Mulder, A., Tops, C., Møller, P., Fodde, R., Menko, F., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808203390804 · Cited by 396
Newcomb, P. A., Baron, J., Cotterchio, M., Gallinger, S., Grove, J., Haile, R., Hall, D., Hopper, J. L., Jass, J., Le Marchand, L., et al. (2007) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0648 · Cited by 389
Self-citationPrediction of Germline Mutations and Cancer Risk in the Lynch Syndrome
Chen, S., Wang, W., Lee, S., Nafa, K., Lee, J., Romans, K., Watson, P., Gruber, S. B., Euhus, D., Kinzler, K. W., et al. (2006) · JAMA · doi:10.1001/jama.296.12.1479 · Cited by 384
Self-citationLadabaum, U., Wang, G., Terdiman, J., Blanco, A., Kuppermann, M., Boland, C. R., Ford, J., Elkin, E., & Phillips, K. A. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-2-201107190-00002 · Cited by 340
Parsons, M. T., Buchanan, D. D., Thompson, B., Young, J. P., & Spurdle, A. B. (2012) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2011-100714 · Cited by 311
Self-citationThe Hereditary Nonpolyposis Colorectal Cancer Syndrome: Genetics and Clinical Implications
Chung, D. C., & Rustgi, A. K. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-7-200304010-00012 · Cited by 306
Self-citationPrediction of MLH1 and MSH2 Mutations in Lynch Syndrome
Balmaña, J., Stockwell, D. H., Steyerberg, E. W., Stoffel, E. M., Deffenbaugh, A. M., Reid, J. E., Ward, B., Scholl, T., Hendrickson, B., Tazelaar, J., et al. (2006) · JAMA · doi:10.1001/jama.296.12.1469 · Cited by 191
Kastrinos, F., Steyerberg, E. W., Mercado, R., Balmaña, J., Holter, S., Gallinger, S., Siegmund, K. D., Church, J. M., Jenkins, M. A., Lindor, N. M., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.08.021 · Cited by 184
Self-citationDomingo, E., Niessen, R. C., Oliveira, C., Alhopuro, P., Moutinho, C., Espín, E., Armengol, M., Sijmons, R. H., Kleibeuker, J. H., Seruca, R., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208569 · Cited by 177
Self-citationInherited Colorectal Cancer Syndromes
Kastrinos, F., & Syngal, S. (2011) · The Cancer Journal · doi:10.1097/ppo.0b013e318237e408 · Cited by 176
Loughrey, M. B., Waring, P. M., Tan, A., Trivett, M., Kovalenko, S., Beshay, V., Young, M.-A., McArthur, G., Boussioutas, A., & Dobrovic, A. (2007) · Familial Cancer · doi:10.1007/s10689-007-9124-1 · Cited by 165
Report From the Jerusalem Workshop on Lynch Syndrome-Hereditary Nonpolyposis Colorectal Cancer
Boland, C. R., & Shike, M. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.04.024 · Cited by 162
Cicek, M. S., Lindor, N. M., Gallinger, S., Bapat, B. V., Hopper, J. L., Jenkins, M. A., Young, J. P., Buchanan, D. D., Walsh, M. D., Marchand, L. L., et al. (2011) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2010.12.004 · Cited by 148
Self-citationBessa, X., Ballesté, B., Andreu, M. G., Castells, A., Bellosillo, B., Balaguer, F., Castellví-Bel, S., Payá, A., Jover, R., Alenda, C., et al. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2007.10.011 · Cited by 92
Self-citationProgress in Genetic Testing, Classification, and Identification of Lynch Syndrome
Vasen, H. F. A. (2005) · JAMA · doi:10.1001/jama.293.16.2028 · Cited by 60
Rodríguez‐Moranta, F., Castells, A., Andreu, M. G., Piñol, V., Castellví-Bel, S., Alenda, C., Llor, X., Xicola, R. M., Jover, R., Payá, A., et al. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00522.x · Cited by 40
Self-citationStoffel, E. M., & Chittenden, A. B. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.09.018 · Cited by 33
Stockman, J. A. (2012) · Yearbook of Pediatrics · doi:10.1016/j.yped.2011.10.040 · Cited by 26
Utility of p16 Immunohistochemistry for the Identification of Lynch Syndrome
Payá, A., Alenda, C., Pérez–Carbonell, L., Rojas, E., Soto, J. L., Guillén‐Ponce, C., Castillejo, A., Barberá, V. M., Carrato, A., Castells, A., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-3116 · Cited by 18
Self-citation
Cited by
Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review
Biller, L. H., & Schrag, D. (2021) · JAMA · doi:10.1001/jama.2021.0106 · Cited by 2,604
Landon, M., Saam, J., Brown, K. L., Moyes, K., Evans, B., & Wenstrup, R. (2015) · Oncology · doi:10.1159/000430097 · Cited by 1,939
Microsatellite Instability as a Biomarker for PD-1 Blockade
Dudley, J. C., Lin, M.-T., Le, D. T., & Eshleman, J. R. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1678 · Cited by 931
Tumor Mutational Burden as a Predictive Biomarker in Solid Tumors
Sha, D., Jin, Z., Budczies, J., Kluck, K., Stenzinger, A., & Sinicrope, F. A. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0522 · Cited by 859
Vasen, H. F. A., Blanco, I., Aktan-Collan, K., Gopie, J. P., Alonso, A., Aretz, S., Bernstein, I., Bertario, L., Burn, J., Capella, G., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-304356 · Cited by 746
Self-citation
Metadata
- Authors
- Moreira, L., Balaguer, F., Lindor, N., de la Chapelle, A., Hampel, H., Aaltonen, L. A., Hopper, J. L., Le Marchand, L., Gallinger, S., Newcomb, P. A., Haile, R., Thibodeau, S. N., Gunawardena, S., Jenkins, M. A., Buchanan, D. D., Potter, J. D., Baron, J. A., Ahnen, D. J., Moreno, V., Andreu, M., Ponz de Leon, M., Rustgi, A. K., Castells, A., & EPICOLON Consortium, F. T.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2012-10-17
- Volume
- 308
- Issue
- 15
- Pages
- 1555
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W1993051520
- Cited by
- 556
- References
- 34
- FWCI
- 24.11
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.